Delivery Order SPE2DB25D3018-SPE2DB26FUWVB
- Not listed
- The Defense Logistics Agency awarded a $4,684.32 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Adderall 20 mg tablets (100 count). This firm fixed-price contract, with an ultimate completion date of August 13, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract is not set-aside and was competitively awarded, with performance of work to occur at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,596.12 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Adderall 20 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,740.47 for Adderall 20 mg tablets (100 count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.86 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units) with a completion deadline of June 2, 2025. This is a competitively awarded, firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,798.06 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units). This firm fixed-price delivery order, awarded on April 24, 2025, represents a non-set-aside competitive procurement with an ultimate completion date of April 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed-price contract valued at $4,431.07, with an ultimate completion date of October 31, 2025. This competitively awarded, non-set-aside delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement needs. The order will be fulfilled from the company's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Adderall 10 mg under a firm fixed-price contract valued at $4,242.68. The order was competitively awarded without set-aside designation and is scheduled for completion by October 27, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $23,424.76 to AmerisourceBergen Drug Corp for Adderall 20 mg tablets (100 count) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,160.91 for 100 tablets of Adderall 15 mg on July 18, 2025, with completion scheduled for July 21, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $4,431.07 and a firm fixed price structure. The contract is non-competitive and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB26FUWVBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,113.04 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed price contract type. This non-set-aside award became effective on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to serve as a critical federal vendor for military and veteran healthcare systems through its extensive pharmaceutical supply capabilities. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The vendor's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its established capability to meet federal procurement requirements for controlled and specialty pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 11/6/25 |